BlackRock
GMAB icon

BlackRock’s Genmab GMAB Stock Holding History

BlackRock’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Buy
4,671,252
+134,687
+3% +$3.58M ﹤0.01% 2072
2026
Q1 		$122M Sell
4,536,565
-57,336
-1% -$1.72M ﹤0.01% 1980
2025
Q4 		$141M Buy
4,593,901
+1,143,375
+33% +$35.6M ﹤0.01% 1894
2025
Q3 		$106M Buy
3,450,526
+284,505
+9% +$6.93M ﹤0.01% 2069
2025
Q2 		$65.4M Sell
3,166,021
-351,831
-10% -$7.22M ﹤0.01% 2300
2025
Q1 		$68.9M Sell
3,517,852
-680,600
-16% -$14.3M ﹤0.01% 2212
2024
Q4 		$87.6M Sell
4,198,452
-418,511
-9% -$9.2M ﹤0.01% 2153
2024
Q3 		$113M Sell
4,616,963
-463,599
-9% -$12.4M ﹤0.01% 2018
2024
Q2 		$128M Buy
5,080,562
+13,429
+0.3% +$381K ﹤0.01% 1888
2024
Q1 		$152M Buy
5,067,133
+657,558
+15% +$19.3M ﹤0.01% 1818
2023
Q4 		$140M Sell
4,409,575
-407,844
-8% -$12.8M ﹤0.01% 1883
2023
Q3 		$170M Sell
4,817,419
-387,087
-7% -$14.8M ﹤0.01% 1650
2023
Q2 		$198M Sell
5,204,506
-43,354
-0.8% -$1.73M 0.01% 1582
2023
Q1 		$198M Sell
5,247,860
-228,185
-4% -$8.77M 0.01% 1541
2022
Q4 		$232M Buy
5,476,045
+206,186
+4% +$8.5M 0.01% 1421
2022
Q3 		$169M Sell
5,269,859
-174,904
-3% -$6.14M 0.01% 1603
2022
Q2 		$177M Sell
5,444,763
-49,926
-0.9% -$1.62M 0.01% 1611
2022
Q1 		$199M Buy
5,494,689
+86,571
+2% +$2.97M 0.01% 1682
2021
Q4 		$214M Sell
5,408,118
-1,446,846
-21% -$60.3M 0.01% 1689
2021
Q3 		$300M Sell
6,854,964
-833,188
-11% -$37.4M 0.01% 1407
2021
Q2 		$314M Buy
7,688,152
+3,462,268
+82% +$134M 0.01% 1445
2021
Q1 		$139M Buy
4,225,884
+597,691
+16% +$22.5M ﹤0.01% 1985
2020
Q4 		$148M Sell
3,628,193
-8,244
-0.2% -$308K ﹤0.01% 1830
2020
Q3 		$133M Buy
3,636,437
+318,230
+10% +$11.5M ﹤0.01% 1700
2020
Q2 		$112M Buy
3,318,207
+855,017
+35% +$23.3M ﹤0.01% 1766
2020
Q1 		$52.2M Buy
2,463,190
+598,785
+32% +$13.3M ﹤0.01% 2019
2019
Q4 		$41.6M Buy
1,864,405
+346,050
+23% +$7.55M ﹤0.01% 2481
2019
Q3 		$30.8M Buy
+1,518,355
New +$29.9M ﹤0.01% 2573

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

BlackRock's GMAB Position: Q2 2026 in Review

BlackRock increased its Genmab (GMAB) stake by 3% in Q2 2026, buying an estimated $3.58M and bringing the position to 4,671,252 shares worth $128M. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

BlackRock first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. The position peaked at $314M in Q2 2021. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • BlackRock held 4,671,252 shares of Genmab worth $128M as of Q2 2026.
  • BlackRock bought 134,687 Genmab shares in Q2 2026, an estimated $3.58M.
  • Genmab made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2072 holding.
  • BlackRock first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
  • BlackRock's Genmab position peaked at $314M in Q2 2021.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.